JP6120133B2 - 人工ポリクローナル免疫グロブリン組成物 - Google Patents

人工ポリクローナル免疫グロブリン組成物 Download PDF

Info

Publication number
JP6120133B2
JP6120133B2 JP2012276866A JP2012276866A JP6120133B2 JP 6120133 B2 JP6120133 B2 JP 6120133B2 JP 2012276866 A JP2012276866 A JP 2012276866A JP 2012276866 A JP2012276866 A JP 2012276866A JP 6120133 B2 JP6120133 B2 JP 6120133B2
Authority
JP
Japan
Prior art keywords
immunoglobulin
artificial
administration
mixture
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012276866A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013147495A5 (enExample
JP2013147495A (ja
Inventor
和男 鈴木
和男 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiba University NUC
Original Assignee
Chiba University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiba University NUC filed Critical Chiba University NUC
Priority to JP2012276866A priority Critical patent/JP6120133B2/ja
Publication of JP2013147495A publication Critical patent/JP2013147495A/ja
Publication of JP2013147495A5 publication Critical patent/JP2013147495A5/ja
Application granted granted Critical
Publication of JP6120133B2 publication Critical patent/JP6120133B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/53—Hinge

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2012276866A 2011-12-19 2012-12-19 人工ポリクローナル免疫グロブリン組成物 Active JP6120133B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012276866A JP6120133B2 (ja) 2011-12-19 2012-12-19 人工ポリクローナル免疫グロブリン組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011277163 2011-12-19
JP2011277163 2011-12-19
JP2012276866A JP6120133B2 (ja) 2011-12-19 2012-12-19 人工ポリクローナル免疫グロブリン組成物

Publications (3)

Publication Number Publication Date
JP2013147495A JP2013147495A (ja) 2013-08-01
JP2013147495A5 JP2013147495A5 (enExample) 2016-02-12
JP6120133B2 true JP6120133B2 (ja) 2017-04-26

Family

ID=48654789

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012276866A Active JP6120133B2 (ja) 2011-12-19 2012-12-19 人工ポリクローナル免疫グロブリン組成物

Country Status (2)

Country Link
US (1) US10208131B2 (enExample)
JP (1) JP6120133B2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10196457B2 (en) 2011-12-19 2019-02-05 National University Corporation Chiba University Artificial immunoglobulin fragment composition
JP6670129B2 (ja) * 2015-02-27 2020-03-18 国立大学法人千葉大学 人工免疫グロブリン断片組成物
AU2018213716B2 (en) * 2017-01-27 2025-01-30 A-Clip Institute, Co. ltd. Prophylactic and/or therapeutic agent of infectious disease or inflammatory disease
EP4549938A4 (en) * 2022-06-30 2026-03-11 A Clip Inst Co Ltd METHOD FOR TESTING DISEASE PROGRESSION TO VASCULARITIS OR RISK OF COVID-19 PROGRESSION TO SEVERE FORM, TEST KIT, COMPANION DIAGNOSTIC AGENT AND TEST MARKER

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4392375B2 (ja) 2004-03-31 2009-12-24 積水化学工業株式会社 人工ポリクローナル免疫グロブリンの製造方法、並びに、免疫グロブリン製剤の製造方法
US20050260710A1 (en) * 2004-03-31 2005-11-24 Sekisui Chemical Co. Ltd. Methods for producing recombinant polyclonal immunoglobulins

Also Published As

Publication number Publication date
US10208131B2 (en) 2019-02-19
JP2013147495A (ja) 2013-08-01
US20130164290A1 (en) 2013-06-27

Similar Documents

Publication Publication Date Title
CN112638406B (zh) 白介素-2变体及其使用方法
US9221887B2 (en) Muteins of tear lipocalin and methods for obtaining the same
KR100391227B1 (ko) 인체의 프로그램화 된 세포사멸과 관련있는 펩티드 및 이를 암호하는 디엔에이(dna)
JP2010506581A (ja) タンパク質変異体
US20160022774A1 (en) Diagnosis and treatment of fibrosis
JPH10503371A (ja) 新規化合物
JPH05507197A (ja) 結合部位を含む可溶性ペプチド類縁体
AU2012228990A1 (en) Potent and selective inhibitors of Nav1.3 and Nav1.7
KR20140091031A (ko) 저밀도 지단백질-관련 단백질 6 (lrp6) - 반감기 연장제 구축물
WO2016177771A9 (en) Single-chain cd40-receptor agonist proteins
KR20240163684A (ko) 항-cd7 나노바디와 이의 유도체 및 종양 치료에서 이의 용도
US20170174736A1 (en) Long-acting recombinant human follicle-stimulating hormone-fc fusion protein
CN116323671A (zh) 具有增加的选择性的多靶向性双特异性抗原结合分子
JP6120133B2 (ja) 人工ポリクローナル免疫グロブリン組成物
JPH08508884A (ja) マクロファージ炎症蛋白変種
JP2026035742A (ja) 生体高分子標的特異的補体阻害剤及びその製造方法と応用
KR19990028314A (ko) 항원에 비특이적인 글리코실레이션 억제인자 유도체
JP3903503B2 (ja) 可溶性ポリペプチド
JPH11500904A (ja) Ｍｐｌリガンド類似体
JP6670129B2 (ja) 人工免疫グロブリン断片組成物
CN101160322A (zh) 分子及其嵌合分子
CN101166760A (zh) 分子及其嵌合分子
US10196457B2 (en) Artificial immunoglobulin fragment composition
CN109071614B (zh) 肺炎球菌溶血素ply截短胜肽及其用途
JPH09289892A (ja) ｃ−ＭＰＬリガンドアゴニスト抗体

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151218

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160927

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20161124

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170126

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170309

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170316

R150 Certificate of patent or registration of utility model

Ref document number: 6120133

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250